ZMYM2 and colorectal carcinoma: These results provide direct evidence that ZMYM2 transcriptionally regulates ANXA9 expression, further supporting the notion that the ZMYM2-ANXA9 axis is a critical pathway in the progression of CRC and a potential target for overcoming chemotherapy resistance.